Market Tracker

09/02 6:05pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.94
Data as of Sep 02
 -0.115 / -1.27%
Today’s Change
5.84
Today|||52-Week Range
11.47
+18.57%
Year-to-Date

Today’s Trading

Previous close9.06
Today’s open9.11
Day’s range8.87 - 9.18
Volume439,056
Average volume (3 months)461,963
Market cap$388.6M
Dividend yield--
Data as of 3:59pm ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+95.03%
Earnings growth (next 5 years)--
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.82

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...+0.05+0.91%
DVAXDynavax Technologies...-0.02-1.41%
SGYPSynergy Pharmaceutic...-0.06-1.54%
IGIGI Laboratories Inc-0.08-1.16%
Data as of 4:00pm ET, 09/02/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.33
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts